120 related articles for article (PubMed ID: 38686746)
1. Long term survival outcomes of surgery combined with hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms: A multicenter retrospective study.
Han Z; Liu X; Tian Y; Shen S; Wang H; Hu S; Wu X; Yan Z; Lu C; Wang P; Bai Y; Kong Y; Wang L; Cao S; Li Z; Zhong H; Meng C; Zhou Y
World J Surg; 2024 Jan; 48(1):86-96. PubMed ID: 38686746
[TBL] [Abstract][Full Text] [Related]
2. Ki67 does not predict recurrence for low-grade appendiceal mucinous neoplasms with peritoneal dissemination after cytoreductive surgery and HIPEC.
Ward EP; Okamuro L; Khan S; Hosseini M; Valasek MA; Ronquillo N; Kelly KJ; Veerapong J; Lowy AM; Baumgartner J
Hum Pathol; 2021 Jul; 113():104-110. PubMed ID: 33905776
[TBL] [Abstract][Full Text] [Related]
3. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Garach NR; Kusamura S; Guaglio M; Bartolini V; Deraco M; Baratti D
Eur J Surg Oncol; 2021 May; 47(5):1132-1139. PubMed ID: 33280949
[TBL] [Abstract][Full Text] [Related]
5. Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin.
Munoz-Zuluaga CA; King MC; Ledakis P; Gushchin V; Sittig M; Nieroda C; Zambrano-Vera K; Sardi A
Eur J Surg Oncol; 2019 Sep; 45(9):1598-1606. PubMed ID: 31109821
[TBL] [Abstract][Full Text] [Related]
6. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
[TBL] [Abstract][Full Text] [Related]
7. Long term survival analysis after hyperthermic intraperitoneal chemotherapy with oxaliplatin as a treatment for appendiceal peritoneal carcinomatosis.
Masckauchan D; Trabulsi N; Dubé P; Aubé-Lecompte ME; Cloutier AS; Mitchell A; Sideris L
Surg Oncol; 2019 Mar; 28():69-75. PubMed ID: 30851915
[TBL] [Abstract][Full Text] [Related]
8. Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC.
Reghunathan M; Kelly KJ; Valasek MA; Lowy AM; Baumgartner JM
Ann Surg Oncol; 2018 Mar; 25(3):702-708. PubMed ID: 29282599
[TBL] [Abstract][Full Text] [Related]
9. Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy.
Sutton PA; O'Dwyer ST; Barriuso J; Aziz O; Selvasekar CR; Renehan AG; Wilson MS
Surg Oncol; 2021 Sep; 38():101572. PubMed ID: 33915487
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
Lam JY; McConnell YJ; Rivard JD; Temple WJ; Mack LA
Am J Surg; 2015 Sep; 210(3):424-30. PubMed ID: 26051744
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (L-CRS/HIPEC) for Perforated Low-Grade Appendiceal Mucinous Neoplasm (LAMN II).
Parkin E; Selvasekar C; Wilson M; Renehan A; O'Dwyer S; Aziz O
Ann Surg Oncol; 2019 Jul; 26(7):2285. PubMed ID: 30989495
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Zambrano-Vera K; Sardi A; Munoz-Zuluaga C; Studeman K; Nieroda C; Sittig M; King MC; Sipok A; Gushchin V
Ann Surg Oncol; 2020 Jan; 27(1):179-187. PubMed ID: 31646450
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience.
Solomon D; Bekhor E; Leigh N; Maniar YM; Totin L; Hofstedt M; Aycart SN; Carr J; Ballentine S; Magge DR; Golas BJ; Pai RK; Polydorides AD; Bartlett DL; Labow DM; Choudry HA; Sarpel U
Ann Surg Oncol; 2020 Jan; 27(1):147-153. PubMed ID: 31385130
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.
Polanco PM; Ding Y; Knox JM; Ramalingam L; Jones H; Hogg ME; Zureikat AH; Holtzman MP; Pingpank J; Ahrendt S; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2016 Feb; 23(2):382-90. PubMed ID: 26429720
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Characteristics of Low-Grade Appendiceal Mucinous Neoplasm.
Yamaguchi T; Murata K; Shiota T; Takeyama H; Noura S; Sakamoto K; Suto T; Takii Y; Nagasaki T; Takeda T; Fujii M; Kagawa Y; Mizushima T; Ohno Y; Yao T; Kishimoto M; Sugihara K;
Dig Surg; 2021; 38(3):222-229. PubMed ID: 33691316
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal Spread of Low-grade Appendiceal Tumours - 2 Days of Early Postoperative Intra-peritoneal Chemotherapy Are Enough.
Rao A; Mui J; Barat S; Matar AA; Alzahrani N; Morris DL
Anticancer Res; 2021 Nov; 41(11):5569-5575. PubMed ID: 34732427
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes for patients with peritoneal acellular mucinosis secondary to low grade appendiceal mucinous neoplasms.
Evans T; Aziz O; Chakrabarty B; Wilson MS; Malcomson L; Lavelle C; O'Dwyer ST
Eur J Surg Oncol; 2021 Jan; 47(1):188-193. PubMed ID: 33092969
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms.
Abudeeb H; Selvasekar CR; O'Dwyer ST; Chakrabarty B; Malcolmson L; Renehan AG; Wilson MS; Aziz O
Surg Endosc; 2020 Dec; 34(12):5516-5521. PubMed ID: 31993814
[TBL] [Abstract][Full Text] [Related]
19. Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection.
Enomoto LM; Choudry MH; Bartlett DL; Totin L; Mann GN; Skitzki JJ; Perry KC; Votanopoulos KI; Levine EA; Shen P
Ann Surg Oncol; 2020 Jan; 27(1):107-114. PubMed ID: 31368017
[TBL] [Abstract][Full Text] [Related]
20. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A
Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
